|
[1]Saranadasa M, Wang ES.Vascular endothelial growth factor inhibi-tion:Conflicting roles in tumor growth[J].Cytokine, 2011, 53 (2) :115-129.
|
|
[2]Farrell GC, Larter CZ.Nonalcoholic fatty liver disease:From steato-sis to cirrhosis[J].Hepatoogy, 2006, 43 (S1) :S99-S112.
|
|
[3]Kitade M, Yoshiji H, Kojima H, et al.Leptin-mediated neovas-cularization is a prerequisite for progression of nonalcoholic steato-hepatitis in rats[J].Hepatology, 2006, 44 (4) :983-991.
|
|
[4]Carpenter B, Lin Y, Stoll S, et al.VEGF is crucial for the hepaticvascular development required for lipoprotein uptake[J].Develop-ment, 2005, 132 (14) :3293-3303.
|
|
[5] LeCouter J, Moritz DR, Li B, et al. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1[J]. Science, 2003, 299 (5608) : 890-893.
|
|
[6]Huanq XD, Fan Y, Zhang H, et al.Serum leptin and soluble lep-tin receptor in non-alcoholic fatty liver disease[J].World J Gas-troenterol, 2008, 14 (18) :2888-93.
|
|
[7]Minicis AD, Seki E, Oesterreicher C, et al.Reduced nicotinamideadenine dinucleotide phosp-hate oxidase mediates fibrotic and in-flammatory effects of leptin on hepatic stellate cells[J].Hepatolo-gy, 2008, 48 (6) :2016-2026.
|
|
[8]Aleffi S, Petral I, Bertolani C, et al.Upregulation of proinflamma-tory and proangiogenic cytokines by leptin in human hepatic stellatecells[J].Hepatology, 2005, 42 (6) :1339-1348.
|
|
[9]Rosmorduc O, Housset C.Hypoxia:a link between fibrogenesis, angiogenesis, and carcinge-nesis in liver disease[J].Semin Liv-er Dis, 2010, 30 (3) :258-270.
|
|
[10]Matsumoto K, Imagawa S, Obara N, et al.2-oxoglutarate down-regulates expression of vasc-ular endothelial growth factor anderythropoietin through decreasing hypoxia-inducible factor-1αand inhibits angiogenesis[J].J Cell Physiol, 2006, 209 (2) :333-340.
|
|
[11]Wang B, Wood IS, Trayhurn P.Hypoxia induces leptin gene ex-pression and secretion in human preadipocytes:differentialeffects of hypoxia on adipokine expression by preadipo-cytes[J].J Endocrinol, 2008, 198 (1) :127-134.
|
|
[12] Wang SN, Chuang SC, Yeh YT, et al. Potential prognostic value of leptin receptor in hepato- cellular carcinoma[J]. Clin Pathol, 2006, 59 (12) : 1267-1271.
|
|
[13]Kaji K, Yoshiji H, Kitade M, et al.Impact of insulin resist-ance on the progression of chronic liver disease[J].Int JMol Med, 2008, 22 (60) :801-808.
|
|
[14]Gomez-Ambrosi J, Catalan V, Rodriguez A, et al.Invove-ment of serum vascular endothelial growth factor familymembers in the development of obesity in mice and humans[J].J Nutr Biochem, 2009, 21 (8) :774-780.
|
|
[15] Prieto-Hontoria PL, Perez-Matute P, Fernandez- Galilea M, et al. Role of obesity- asssociated dysfunctional adipose tissue in cancer: A molecular nutrition approach[J]. Biochim Biophys Acta, 2010, 1807 (6) : 664-678.
|
|
[16] Varela-Rey M, Embade N, Ariz U, et al. Non-alcoholic steatohepatitis and animal models: understanding the human disease[J]. Int J Biochem Cell B, 2009, 41 (5) : 969-976.
|
|
[17]Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ.Adipo-kines in nonalcoholic steatoheaptitis:from pathogenesis to im-plications in disgnosis and therapy[M].Hindawi Publishing Cor-poration:Mediators of Inflammation, 2009:1-8.
|
|
[18]Horiguchi N, Takayama H, Toyoda M, et al.Hepatocyte growthfactor promotes hepatocarci-nogenesis through c-Mel auto-crine activation and enhanced angiogenesis in transgenic micetreated with diethylnitrosamine[J].Oncogene, 2002, 21 (12) :1791-1799.
|
|
[19]Farrell GC, Chitturi S, Lau GK, et al.Guidelines for the as-sessment and management of non-alcoholic fatty liver dis-ease in the Asia-Pacific region:executive summary[J].JGastroen Hepatol, 2007, 22 (6) :775-777.
|
|
[20]Starley BQ, Calcagno CJ, Harrison SA.Nonalcoholic Fatty LiverDisease and Hepatocellular Carcinoma:A Weighty Connection[J].Hepatology, 2010, 51 (5) :1820-1832.
|
DownLoad: